(BAK) Braskem - Overview

Exchange: NYSE • Country: Brazil • Currency: USD • Type: Common Stock • ISIN: US1055321053

Stock: Polyethylene, Polypropylene, Petrochemicals, Fuels, Electricity

Total Rating 29

Risk 63

Buy Signal 0.56

Chemicals » Commodity Chemicals
Age: 27.1y

Market Cap: 1,415m
Avg Trading Vol: 5.65M USD

ATR: 5.93%
Peers RS (IBD): 63.16

EPS (Earnings per Share)

EPS CAGR: -13.87%
EPS Trend: 1.5%

Last SUE: 0.94
Qual. Beats: 2

Revenue

Rev. CAGR: -12.23%
Rev. Trend: -11.6%

Last SUE: 0.00
Qual. Beats: 0

Risk 5d forecast
Volatility	57.6%
Relative Tail Risk	-10.5%

Reward TTM
Sharpe Ratio	-0.10
Alpha	-38.32

Character TTM
Beta	1.201
Beta Downside	0.664

Drawdowns 3y
Max DD	81.02%
CAGR/Max DD	-0.31

Description: BAK Braskem January 16, 2026

Braskem S.A. (NYSE: BAK) is Brazil’s largest petrochemical producer, manufacturing a broad portfolio that includes polyethylene, polypropylene, PVC, and key petrochemical intermediates such as ethylene, propylene, benzene, and butadiene. The company also offers utility services (steam, water, compressed air, industrial gases) and operates a diversified geographic footprint spanning the Americas, Europe, and Asia.

Key operational metrics: Braskem’s 2023 adjusted EBITDA margin was roughly 13%, supported by a 7 Mt/yr polyethylene capacity and a 5 Mt/yr polypropylene capacity. The firm’s earnings are highly sensitive to feedstock pricing-Brazil’s shift from naphtha to cheaper ethane imports can swing margins by 2-3 percentage points. Additionally, Braskem’s debt-to-EBITDA ratio has improved to about 2.1× after a 2022 debt-reduction program, enhancing financial flexibility.

For a deeper, data-driven look at Braskem’s valuation scenarios and risk factors, explore the analysis available on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 2.0

Net Income: -5.24b TTM > 0 and > 6% of Revenue
FCF/TA: -0.07 > 0.02 and ΔFCF/TA -5.53 > 1.0
NWC/Revenue: 5.32% < 20% (prev 10.02%; Δ -4.71% < -1%)
CFO/TA -0.03 > 3% & CFO -2.48b > Net Income -5.24b
Net Debt (56.57b) to EBITDA (3.54b): 16.00 < 3
Current Ratio: 1.18 > 1.5 & < 3
Outstanding Shares: last quarter (398.5m) vs 12m ago 0.0% < -2%
Gross Margin: 4.41% > 18% (prev 0.08%; Δ 433.4% > 0.5%)
Asset Turnover: 81.95% > 50% (prev 80.90%; Δ 1.05% > 0%)
Interest Coverage Ratio: -0.25 > 6 (EBITDA TTM 3.54b / Interest Expense TTM 5.27b)

Altman Z'' -0.35

A: 0.04 (Total Current Assets 26.27b - Total Current Liabilities 22.35b) / Total Assets 87.38b
B: -0.16 (Retained Earnings -13.62b / Total Assets 87.38b)
C: -0.01 (EBIT TTM -1.30b / Avg Total Assets 90.02b)
D: -0.04 (Book Value of Equity -3.53b / Total Liabilities 90.56b)
Altman-Z'' Score: -0.35 = B

Beneish M -2.51

DSRI: 0.67 (Receivables 3.11b/4.74b, Revenue 73.77b/74.95b)
GMI: 1.77 (GM 4.41% / 7.82%)
AQI: 1.23 (AQ_t 0.22 / AQ_t-1 0.18)
SGI: 0.98 (Revenue 73.77b / 74.95b)
TATA: -0.03 (NI -5.24b - CFO -2.48b) / TA 87.38b)
Beneish M-Score: -2.51 (Cap -4..+1) = A

What is the price of BAK shares?

As of February 08, 2026, the stock is trading at USD 3.64 with a total of 1,483,944 shares traded.
Over the past week, the price has changed by +2.54%, over one month by +20.53%, over three months by +51.04% and over the past year by -20.18%.

Is BAK a buy, sell or hold?

Braskem has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold BAK.

StrongBuy: 2
Buy: 0
Hold: 6
Sell: 0
StrongSell: 0

What are the forecasts/targets for the BAK price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	3.7	0.8%
Analysts Target Price	3.7	0.8%
ValueRay Target Price	3.3	-9.6%

BAK Fundamental Data Overview February 03, 2026

Market Cap BRL = 7.41b (1.41b USD * 5.2395 USD.BRL)
P/E Forward = 9.7847
P/S = 0.0192
P/B = 181.0163
P/EG = -1.31
Revenue TTM = 73.77b BRL
EBIT TTM = -1.30b BRL
EBITDA TTM = 3.54b BRL
Long Term Debt = 57.15b BRL (from longTermDebt, last quarter)
Short Term Debt = 2.94b BRL (from shortTermDebt, last quarter)
Debt = 63.24b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 56.57b BRL (from netDebt column, last quarter)
Enterprise Value = 67.51b BRL (7.41b + Debt 63.24b - CCE 3.13b)
Interest Coverage Ratio = -0.25 (Ebit TTM -1.30b / Interest Expense TTM 5.27b)
EV/FCF = -11.10x (Enterprise Value 67.51b / FCF TTM -6.08b)
FCF Yield = -9.01% (FCF TTM -6.08b / Enterprise Value 67.51b)
FCF Margin = -8.25% (FCF TTM -6.08b / Revenue TTM 73.77b)
Net Margin = -7.10% (Net Income TTM -5.24b / Revenue TTM 73.77b)
Gross Margin = 4.41% ((Revenue TTM 73.77b - Cost of Revenue TTM 70.51b) / Revenue TTM)
Gross Margin QoQ = 2.52% (prev 2.03%)
Tobins Q-Ratio = 0.77 (Enterprise Value 67.51b / Total Assets 87.38b)
Interest Expense / Debt = 0.42% (Interest Expense 263.2m / Debt 63.24b)
Taxrate = 21.0% (US default 21%)
NOPAT = -1.03b (EBIT -1.30b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.18 (Total Current Assets 26.27b / Total Current Liabilities 22.35b)
Debt / Equity = -17.90 (negative equity) (Debt 63.24b / totalStockholderEquity, last quarter -3.53b)
Debt / EBITDA = 16.00 (Net Debt 56.57b / EBITDA 3.54b)
Debt / FCF = -9.30 (negative FCF - burning cash) (Net Debt 56.57b / FCF TTM -6.08b)
Total Stockholder Equity = -4.09b (last 4 quarters mean from totalStockholderEquity)
RoA = -5.82% (Net Income -5.24b / Total Assets 87.38b)
RoE = 128.2% (negative equity) (Net Income TTM -5.24b / Total Stockholder Equity -4.09b)
RoCE = -2.45% (EBIT -1.30b / Capital Employed (Equity -4.09b + L.T.Debt 57.15b))
RoIC = -1.72% (negative operating profit) (NOPAT -1.03b / Invested Capital 59.60b)
WACC = 1.38% (E(7.41b)/V(70.65b) * Re(10.34%) + D(63.24b)/V(70.65b) * Rd(0.42%) * (1-Tc(0.21)))
Discount Rate = 10.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.02%
Fair Price DCF = unknown (Cash Flow -6.08b)
EPS Correlation: 1.48 | EPS CAGR: -13.87% | SUE: 0.94 | # QB: 2
Revenue Correlation: -11.55 | Revenue CAGR: -12.23% | SUE: -0.00 | # QB: 0
EPS next Year (2026-12-31): EPS=-1.80 | Chg30d=+0.041 | Revisions Net=+0 | Growth EPS=-490.4% | Growth Revenue=+6.8%

Additional Sources for BAK Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle